These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [TBL] [Abstract][Full Text] [Related]
45. Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency. Pawlak M; Baugé E; Lalloyer F; Lefebvre P; Staels B Mol Endocrinol; 2015 Aug; 29(8):1134-43. PubMed ID: 26087172 [TBL] [Abstract][Full Text] [Related]
46. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis. Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386 [TBL] [Abstract][Full Text] [Related]
47. PPARα is essential for retinal lipid metabolism and neuronal survival. Pearsall EA; Cheng R; Zhou K; Takahashi Y; Matlock HG; Vadvalkar SS; Shin Y; Fredrick TW; Gantner ML; Meng S; Fu Z; Gong Y; Kinter M; Humphries KM; Szweda LI; Smith LEH; Ma JX BMC Biol; 2017 Nov; 15(1):113. PubMed ID: 29183319 [TBL] [Abstract][Full Text] [Related]
48. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts. Gélinas R; Labarthe F; Bouchard B; Mc Duff J; Charron G; Young ME; Des Rosiers C Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1571-80. PubMed ID: 18223187 [TBL] [Abstract][Full Text] [Related]
49. Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. Le May C; Pineau T; Bigot K; Kohl C; Girard J; Pégorier JP FEBS Lett; 2000 Jun; 475(3):163-6. PubMed ID: 10869548 [TBL] [Abstract][Full Text] [Related]
50. mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis. Selen ES; Wolfgang MJ J Biol Chem; 2021 Jul; 297(1):100884. PubMed ID: 34146544 [TBL] [Abstract][Full Text] [Related]
51. Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle? Finck BN Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):161-71. PubMed ID: 16509812 [TBL] [Abstract][Full Text] [Related]
59. Mitochondrial Fatty Acid β-Oxidation Inhibition Promotes Glucose Utilization and Protein Deposition through Energy Homeostasis Remodeling in Fish. Li LY; Li JM; Ning LJ; Lu DL; Luo Y; Ma Q; Limbu SM; Li DL; Chen LQ; Lodhi IJ; Degrace P; Zhang ML; Du ZY J Nutr; 2020 Sep; 150(9):2322-2335. PubMed ID: 32720689 [TBL] [Abstract][Full Text] [Related]
60. Metabolic and genetic regulation of cardiac energy substrate preference. Kodde IF; van der Stok J; Smolenski RT; de Jong JW Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan; 146(1):26-39. PubMed ID: 17081788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]